Search results
35%
- Dr. Lal PathLabs – At a Glance 12% 3 Year Revenue CAGR 35% ROCE 240%
media.lalpathlabs.com/2024-05/Corporate-Presentation-Q4FY24.pdfCorporate Presentation Dr Lal PathLabs May 2024 Limited (DLPL)
People also ask
What is Dr Lal PathLabs share price?
What is the CAGR of Dr Lal PathLabs?
Who is Dr Lal PathLabs Limited?
Why should you choose Lal PathLabs?
Sep 20, 2024 · Dr Lal Pathlabs share price was Rs 3,279.95 as on 27 Sep, 2024, 10:11 AM IST. Dr Lal Pathlabs share price was down by 0.04% based on previous share price of Rs 3,331.2. Dr Lal Pathlabs share price trend: Last 1 Month: Dr Lal Pathlabs share price moved down by 1.96%; Last 3 Months: Dr Lal Pathlabs share price moved up by 19.36%
- As on 05 Jan, 2024, 03:58 PM IST Dr Lal Pathlabs share price was down by 1.55% basis the previous closing price of Rs 2,638.05. Dr Lal Pathlabs sha...
- Within the Hospitals & Allied Services sector, Dr Lal Pathlabs stock has a market cap rank of 6. Dr Lal Pathlabs has a market cap of Rs 21,682.13 Cr.
- In last 52 weeks Dr Lal Pathlabs share had a high price of Rs 2,767.10 and low price of Rs 1,762.05
- Top 4 Peers for Dr Lal Pathlabs are Metropolis Healthcare Ltd., Vijaya Diagnostic Centre Ltd., Thyrocare Technologies Ltd. and Krsnaa Diagnostics Ltd.
- Promoter,DII and FII owns 55.01, 8.34 and 23.27 shares of Dr Lal Pathlabs as on 30 Sep 2023Promoter holding have gone down from 55.01 (30 Jun 2023)...
- Dr Lal Pathlabs share can be quickly analyzed on following metrics: Stock's PE is 71.94 Price to Book Ratio of 12.66 Dividend Yield of 0.46 EPS (tr...
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and ...
2 days ago · The share price of Dr Lal Pathlabs Ltd is ₹3,271.85 (NSE) and ₹3,275.70 (BSE) as of 27-Sep-2024 IST. Dr Lal Pathlabs Ltd has given a return of -5.6% in the last 3 years.
- ₹3,375.10 - ₹3,432.15
- Dr. Lal Pathlabs Ltd.
- The total asset value of Dr. Lal Pathlabs Ltd. stood at ₹ 2,445 Cr as on 30-Sep-23
- The share price of Dr. Lal Pathlabs Ltd. is ₹2,644.80 (NSE) and ₹2,643.05 (BSE) as of 02-Jan-2024 IST. Dr. Lal Pathlabs Ltd. has given a return of...
- Dr. Lal Pathlabs Ltd. has a market capitalisation of ₹ 21,938 Cr as on 02-Jan-2024. As per Value Research classification, it is a Mid Cap company.
- The P/B ratio of Dr. Lal Pathlabs Ltd. is 12.38 times as on 02-Jan-2024, a 0.41% premium to its peers’ median range of 8.81 times.
- The P/E ratio of Dr. Lal Pathlabs Ltd. is 72.79 times as on 02-Jan-2024, a 0.57% premium to its peers’ median range of 46.35 times.
- Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC Step...
- Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally. The co...
- The prominent promoters of Dr. Lal Pathlabs Ltd. are Name of promoters Holding percentage Arvind Lal 31.29% Vandana Lal 19.27% Archana Lal Erdma...
- The promoters of Dr. Lal Pathlabs Ltd. have pledged 0% of the total equity as on Sep-23.
2 days ago · Dr Lal PathLab Share Price: Find the latest news on Dr Lal PathLab Stock Price. Get all the information on Dr Lal PathLab with historic price charts for NSE / BSE.
- 3,380.20
- 2,521.00
- 3,377.80
- 74,231.00
70+ years of experience in 122 Mn patients serviced the field of diagnostics in last 5 years. India’s Leading & Trusted Diagnostics 36 NABL accredited Company Labs; 2 CAP accredited Labs. Largest* diagnostics chain in the country with PAN India presence and consistent track record of quality and growth.
5 days ago · Dr. Lal Path Labs Ltd. Stock Price Today, Live NSE Share Price: Get the latest Dr. Lal Path Labs Ltd. news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
